Published in Brain Res Rev on July 30, 2008
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44
Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci (2012) 2.87
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology (2012) 2.78
Review of recent advances in analytical techniques for the determination of neurotransmitters. Anal Chim Acta (2009) 1.68
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain (2014) 1.59
Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull (2009) 1.45
Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. PLoS One (2011) 1.27
Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry (2011) 1.20
Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry (2012) 1.17
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia. Front Cell Neurosci (2013) 1.12
New insights on NOX enzymes in the central nervous system. Antioxid Redox Signal (2014) 1.06
Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia. Neuroscience (2011) 1.03
Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits. CNS Neurosci Ther (2013) 0.98
Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats. Psychopharmacology (Berl) (2011) 0.90
D-serine as a gliotransmitter and its roles in brain development and disease. Front Cell Neurosci (2013) 0.89
RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophrenia. J Neurosci (2010) 0.89
The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Int J Neuropsychopharmacol (2014) 0.88
Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings. Schizophr Bull (2015) 0.88
Behavioral effects of prenatal ketamine exposure in rhesus macaques are dependent on MAOA genotype. Exp Clin Psychopharmacol (2012) 0.87
Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity. Front Psychiatry (2011) 0.86
Antidepressant mechanism of ketamine: perspective from preclinical studies. Front Neurosci (2015) 0.85
Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain. Brain Res (2011) 0.85
The GluK4 kainate receptor subunit regulates memory, mood, and excitotoxic neurodegeneration. Neuroscience (2013) 0.85
Prolonged exposure to NMDAR antagonist induces cell-type specific changes of glutamatergic receptors in rat prefrontal cortex. Neuropharmacology (2011) 0.84
Impaired cognitive function and altered hippocampal synapse morphology in mice lacking Lrrtm1, a gene associated with schizophrenia. PLoS One (2011) 0.84
Blockade of hindbrain NMDA receptors containing NR2 subunits increases sucrose intake. Am J Physiol Regul Integr Comp Physiol (2009) 0.83
Deficits in emotional learning and memory in an animal model of schizophrenia. Behav Brain Res (2012) 0.82
Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats. Pharmacol Biochem Behav (2013) 0.81
Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain. PLoS One (2015) 0.81
NMDA receptor hypofunction induces dysfunctions of energy metabolism and semaphorin signaling in rats: a synaptic proteome study. Schizophr Bull (2010) 0.81
Gestational methylazoxymethanol exposure leads to NMDAR dysfunction in hippocampus during early development and lasting deficits in learning. Neuropsychopharmacology (2012) 0.80
NADPH oxidase-2: linking glucose, acidosis, and excitotoxicity in stroke. Antioxid Redox Signal (2015) 0.80
Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys. Psychopharmacology (Berl) (2010) 0.79
Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist. Psychopharmacology (Berl) (2010) 0.78
Behavioural studies with a newly developed neuroprotective KYNA-amide. J Neural Transm (Vienna) (2011) 0.78
The role of D-serine as co-agonist of NMDA receptors in the nucleus accumbens: relevance to cocaine addiction. Front Synaptic Neurosci (2014) 0.78
Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist. Neuropsychopharmacology (2012) 0.78
Restructuring consciousness -the psychedelic state in light of integrated information theory. Front Hum Neurosci (2015) 0.78
Adenosine neuromodulation and traumatic brain injury. Curr Neuropharmacol (2009) 0.78
40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors. Neuropsychopharmacology (2016) 0.77
Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes. Front Cell Neurosci (2016) 0.76
Altered neuronal excitability underlies impaired hippocampal function in an animal model of psychosis. Front Behav Neurosci (2015) 0.76
Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype. Neuropsychopharmacology (2015) 0.76
A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms. EMBO Mol Med (2017) 0.76
Ketamine Protects Gamma Oscillations by Inhibiting Hippocampal LTD. PLoS One (2016) 0.75
Preclinical non-human models to combat dementia. Ann Neurosci (2013) 0.75
Testing synaptic plasticity in dynamic mate choice decisions: N-methyl D-aspartate receptor blockade disrupts female preference. Proc Biol Sci (2014) 0.75
Ketamine: differential neurophysiological dynamics in functional networks in the rat brain. Transl Psychiatry (2017) 0.75